Precigen (PGEN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
Meeting called to order by the chairman, with board members and executive leadership introduced.
Virtual meeting procedures and technical support information provided to attendees.
Inspector of Election and independent auditor representatives present for proceedings.
Confirmation of proper notice and availability of annual report and proxy statement.
Board and executive committee updates
Nine nominees for the board of directors presented for election to serve one-year terms.
Shareholder proposals
Four proposals presented: election of directors, ratification of auditor, advisory vote on executive compensation, and amendment to the 2023 Omnibus Incentive Plan.
No questions or comments received from shareholders on any proposal.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Precigen
- Rapidly approved gene therapy for RRP sees strong uptake and expansion into new markets.PGEN
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - PAPZIMEOS launch drove $21.6M Q1 revenue, rapid adoption, and a sharply narrowed net loss.PGEN
Q1 202619 May 2026 - Shareholders will vote on director elections, auditor ratification, executive pay, and a key equity plan amendment.PGEN
Proxy filing30 Apr 2026 - Virtual meeting to vote on directors, auditor, compensation, and incentive plan amendment.PGEN
Proxy filing30 Apr 2026 - PAPZIMEOS sets a new standard for RRP, fueling growth and pipeline expansion via a unique platform.PGEN
Fireside chat3 Apr 2026 - PAPZIMEOS launch accelerates revenue growth and adoption, with Q1 2026 revenue set to exceed $18M.PGEN
Q4 202525 Mar 2026 - PAPZIMEOS launch accelerates adoption and revenue, but non-cash charges drive Q3 net loss.PGEN
Q3 20253 Feb 2026 - PRGN-2012 pivotal data and focus drive new funding, but losses and going concern risks persist.PGEN
Q2 20241 Feb 2026 - 51% complete response and 86% surgery reduction with durable benefit and strong safety.PGEN
Study Result31 Jan 2026